JPMorgan has made the case that the best place for investors to look when considering large cap drug stocks is companies that have strong new product cycles already in motion.
24/7 Wall St. has put together a preview of some of the world’s largest biotech and pharma companies reporting their earnings on Thursday.
The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
With interest rates once again dropping as the geopolitical worries ratchet up, investors are concerned about owning good stocks and receiving dependable dividends. One place that looks very good now is pharmaceuticals.
The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of these selected pharmaceutical stocks.
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
Esperion Therapeutics and a few other biopharma stocks made massive runs on Monday morning.
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Giddy investors continued pouring money into U.S. stocks last week, and insiders continued their steady purchases at companies where they work or have a large position on file.
Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.
Tuesday, February 21, 2017, saw three large companies in the news after activist investors have targeted them. Investors have taken mixed reactions to each effort.
2016's 50 most innovative companies are topped by Apple, Google and Tesla. Among the companies making the biggest moves were Netflix and Facebook, and new entrants on the list included Uber and…
It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far the reaction has been quite positive.
Bristol-Myers, Mattel, DryShips, and FuelCell Energy posted new 52-week lows Thursday.
The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly down.
